Bausch Health Companies Inc.
HealthcareNYSE:BHC · New York Stock Exchange
-$0.10 today
Vol 1.56M · Avg 1.70M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.3B |
| Receivables | $2.2B |
| Inventory | $1.6B |
| Other Current | $887.0M |
| Total Current Assets | $6.0B |
| PP&E (Net) | $2.1B |
| Goodwill | $9.8B |
| Intangible Assets | $4.4B |
| Tax Assets | $1.8B |
| Other Non-current | $369.0M |
| Total Non-current Assets | $18.5B |
| Total Assets | $24.5B |
Analysis
Selected assets total $24.5B for Latest. The largest visible component is Goodwill at $9.8B, about 40.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.3B +12.0% | $1.2B +24.7% | $947.0M +67.9% | $564.0M -3.1% | $582.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $2.3B +9.7% | $2.1B +7.1% | $2.0B +11.6% | $1.8B +0.8% | $1.8B | $533.8M | $399.4M | -$1.7B |
| Inventory | $1.6B +1.9% | $1.6B +3.3% | $1.5B +41.7% | $1.1B +9.8% | $993.0M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $850.4M -0.9% | $858.0M -22.5% | $1.1B +2738.5% | $39.0M -97.5% | $1.5B | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $6.1B +6.4% | $5.8B +3.2% | $5.6B +31.8% | $4.2B -24.3% | $5.6B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.1B +16.3% | $1.8B +4.3% | $1.7B +6.7% | $1.6B +0.1% | $1.6B | $1.2B | $1.5B | $687.8M |
| Goodwill | $11.3B +1.5% | $11.1B -0.9% | $11.2B -3.2% | $11.5B -7.3% | $12.5B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $4.6B -16.5% | $5.6B -14.0% | $6.5B +11.3% | $5.8B -16.5% | $6.9B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $1.8B -6.5% | $2.0B -6.3% | $2.1B -3.0% | $2.2B -3.8% | $2.3B | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $377.3M +3.9% | $363.0M +18.2% | $307.0M -5.8% | $326.0M -4.1% | $340.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $20.2B -2.8% | $20.7B -4.6% | $21.8B +1.5% | $21.4B -9.1% | $23.6B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $26.3B -0.8% | $26.5B -3.0% | $27.4B +6.5% | $25.7B -12.0% | $29.2B | $13.3B | $11.9B | $10.6B |
| Account Payables | $598.9M -8.7% | $656.0M -8.8% | $719.0M +38.0% | $521.0M +28.0% | $407.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $296.5M -88.9% | $2.7B +494.2% | $450.0M +4.2% | $432.0M | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $63.0M +34.0% | $47.0M +56.7% | $30.0M -69.4% | $98.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $2.9B +115.1% | $1.3B -5.3% | $1.4B +4.6% | $1.3B -55.0% | $3.0B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $4.2B -38.2% | $6.8B +57.0% | $4.3B +9.2% | $3.9B -24.2% | $5.2B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $20.7B +9.4% | $18.9B -13.7% | $21.9B +7.9% | $20.3B -10.2% | $22.7B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $146.7M +14.6% | $128.0M -21.5% | $163.0M -19.3% | $202.0M -61.8% | $529.0M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $711.7M -17.0% | $857.5M -16.7% | $1.0B +8.4% | $949.0M +11.0% | $855.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $21.8B +8.3% | $20.1B -13.1% | $23.1B +7.7% | $21.5B -10.6% | $24.0B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $25.9B -3.4% | $26.8B -2.1% | $27.4B +7.9% | $25.4B -13.0% | $29.2B | $14.7B | $3.7B | $9.6B |
| Common Stock | $10.5B +0.1% | $10.5B +0.6% | $10.4B +0.3% | $10.4B +0.7% | $10.3B | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$9.6B +1.8% | -$9.8B -0.5% | -$9.8B -6.4% | -$9.2B -2.5% | -$9.0B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$1.8B +19.4% | -$2.2B -15.8% | -$1.9B +8.5% | -$2.1B -6.9% | -$1.9B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $929.3M -2.9% | $957.0M +1.8% | $940.0M -1.3% | $952.0M +1222.2% | $72.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $376.3M +216.9% | -$322.0M -292.7% | -$82.0M -131.5% | $260.0M +864.7% | -$34.0M | $9.1B | $7.7B | $3.3B |
| Total Debt | $21.2B -2.8% | $21.8B -2.5% | $22.4B +7.8% | $20.8B -8.3% | $22.7B | $724.2M | $410.6M | $399.4M |
| Net Debt | $19.9B -3.7% | $20.6B -3.7% | $21.4B +6.1% | $20.2B -8.5% | $22.1B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
Haemonetics Corporation
NYSE:HAE
$3.55B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.02B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.91B
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
$1.86B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.57B
Perrigo Company plc
NYSE:PRGO
$1.52B
Alvotech
NASDAQ:ALVO
$1.30B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does BHC have?
Bausch Health Companies Inc. (BHC) reported $1.32B in cash and equivalents in fiscal 2025.
How much debt does BHC carry?
Bausch Health Companies Inc. (BHC) reported $21.21B of total debt, with net debt of $19.88B.
Explore More
Continue the stock analysis
Jump to another research area for this company.